Correction: PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer

  • Gordon C Wishart1, 7Email author,

    Affiliated with

    • Elizabeth M Azzato2, 3,

      Affiliated with

      • David C Greenberg4,

        Affiliated with

        • Jem Rashbass4,

          Affiliated with

          • Olive Kearins5,

            Affiliated with

            • Gill Lawrence5,

              Affiliated with

              • Carlos Caldas1, 6, 7, 8 and

                Affiliated with

                • Paul DP Pharoah2

                  Affiliated with

                  Breast Cancer Research201012:401

                  DOI: 10.1186/bcr2480

                  Published: 1 March 2010

                  Following the publication of our article [1] we noticed an error in Table 1 relating to the number of patients who received adjuvant therapy. The correct table is given here (Table 1).
                  Table 1

                  Patient characteristics for model development (ECRIC) and validation (WMCIU) cohorts

                   

                  ECRIC

                   

                  WMCIU

                   

                  Total Number of Subjects

                  5,694

                   

                  5,468

                   

                  Total time at risk (years)

                  31,904

                   

                  25,917

                   

                  Median follow-up (years)*

                  5.65

                  (0.04-8.00)

                  4.85

                  (0.07-8.00)

                  Number of breast cancer deaths

                  737

                   

                  668

                   

                  Number of other deaths

                  338

                   

                  287

                   

                  Annual breast cancer mortality rate

                  0.023

                  (0.021-0.025)

                  0.026

                  (0.024-0.028)

                  5-year breast cancer survival rate

                  0.89

                  (0.88-0.90)

                  0.88

                  (0.87-0.89)

                  Median age at diagnosis, years

                  58

                  (23-95)

                  58

                  (22-93)

                   

                  Number

                  %

                  Number

                  %

                  Age, years

                      

                     <35

                  111

                  2

                  108

                  2

                     35-49

                  1,172

                  21

                  1,195

                  22

                     50-64

                  2,630

                  46

                  2,393

                  44

                     65-74

                  1,124

                  20

                  1,101

                  20

                     75+

                  657

                  12

                  671

                  12

                  Nodal status

                      

                     0

                  3,532

                  62

                  3,184

                  58

                     1

                  741

                  13

                  746

                  14

                     2-4

                  806

                  14

                  792

                  14

                     5-9

                  380

                  7

                  451

                  8

                     10+

                  235

                  4

                  295

                  5

                  Tumour size, mm

                      

                     <10

                  625

                  11

                  485

                  9

                     10-19

                  2,310

                  41

                  2,136

                  39

                     20-29

                  1,627

                  29

                  1,566

                  29

                     30-49

                  845

                  15

                  923

                  17

                     50+

                  287

                  5

                  358

                  7

                  Grade

                      

                     I

                  1,005

                  18

                  1,017

                  19

                     II

                  2,927

                  51

                  2,442

                  45

                     III

                  1,762

                  31

                  2,009

                  37

                  ER Status

                      

                     ER negative

                  991

                  17

                  1,116

                  20

                     ER positive

                  4,703

                  83

                  4,352

                  80

                  Adjuvant therapy

                      

                     None

                  643

                  11

                  1,520

                  28

                     Chemotherapy only

                  783

                  14

                  1,542

                  28

                     Endocrine therapy

                  3,146

                  55

                  1,827

                  33

                     Combined chemoendocrine

                  1,122

                  20

                  579

                  11

                  Screen detected

                      

                     Yes

                  1,621

                  28

                  1,256

                  23

                     No

                  4,073

                  72

                  4,212

                  77

                  *Follow-up censored at 8 years

                  Range of variable

                  95 CI

                  Authors’ Affiliations

                  (1)
                  Cambridge Breast Unit, Addenbrooke's Hospital
                  (2)
                  Strangeways Research Laboratory, Department of Oncology, University of Cambridge
                  (3)
                  Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute
                  (4)
                  Eastern Cancer Registration and Information Centre (ECRIC)
                  (5)
                  West Midlands Cancer Intelligence Unit, Public Health Building, The University of Birmingham
                  (6)
                  Department of Oncology, University of Cambridge
                  (7)
                  Functional Breast Cancer Genomics Laboratory, Cancer Research UK Cambridge Research Institute, Li Ka-Shing Centre
                  (8)
                  National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre, Addenbrooke's Hospital

                  References

                  1. Wishart GC, Azzato EM, Greenberg DC, Rashbass J, Kearins O, Lawrence G, Caldas C, Pharoah PD: PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer. Breast Cancer Res 2010, 12:R1.PubMedView Article

                  Copyright

                  © BioMed Central Ltd 2010

                  Advertisement